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Chemical biology is an interdisciplinary field of study that is often defined as 
“chemistry-initiated biology.” As biological processes all stem from chemical events, it 
should be possible to understand or manipulate biological events by using chemistry. Our 
laboratory has been discovering or designing unique organic molecules that modulate 
fundamental processes in human cells. Our mission is to create new world of bioactive 
synthetic molecules: their new way to use, their new shapes, and their new sizes. We hope 
to open new avenues for small-molecule applications in a range of fields, including future 
concepts in drug discovery and use of small molecules for cell therapy.
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A Mitochondrial Surface-specific Fluorescent 
Probe Activated by Bioconversion
We carried out cell-based  image screening of 12,000 
small molecules enriched in aromatic groups and identified 
thirty-one that had potential as fluorescent probes for living 
cells. One of the candidates appeared to selectively stain 
mitochondrial surfaces. Results of spectroscopic analyses 
and chemical synthesis indicated that the molecule under-
went metabolic cyclization to be fluorescent inside cells. 
To our knowledge, this molecule represents the first fluo-
rescent probe specific for mitochondrial surfaces.
Cell-morphology Profiling of a Natural 
Product Library
Natural products provide a rich source of biological tools, 
but elucidating their molecular targets remains challenging. 
We carried out a cell morphological profiling of a natural 
product library, which permitted the identification of bise-
bromoamide and miuraenamide A as actin filament stabi-
lizers. Automated high-content image analysis showed 
that these two structurally distinct marine natural products 
induce morphological changes in HeLa cells similar to 
those induced by known actin-stabilizing compounds. 
Bisebromoamide and miuraenamide A stabilized actin 
 filaments in vitro, and fluorescein-conjugated bisebromo-
amide localized specifically to actin filaments in cells. 
Cell morphological profiling was also used to identify 
 actin-stabilizing or -destabilizing natural products from 
marine sponge extracts, leading to the isolation of 
 pectenotoxin-2 and lyngbyabellin C. Overall, the results 
demonstrate that high-content imaging of nuclei and cell 
shapes offers a sensitive and convenient method for 
 detecting and isolating molecules that target actin.
Discovery of FGH10019
In 2009, our group reported the discovery and synthesis 
of “fatostatin,” a small molecule that inhibits activation of 
sterol regulatory element-binding protein (SREBP). 
 Fatostatin blocks biosynthesis and accumulation of fat in 
obese mice. We newly synthesized and evaluated a series 
of fatostatin derivatives. Our structure-activity relation-
ships led to the identification of FGH10019 as the most 
potent drug-like molecule among the analogues tested. 
FGH10019 has high aqueous solubility and membrane 
permeability and may serve as a seed molecule for further 
development.
Small-molecule Fluorescent Probes for 
Specific RNA Targets
A method was developed that uses small molecules as 
fluorescent probes to detect specific mRNAs. In this 
 approach, the fluorescence of fluorophore-quencher con-
jugates is restored by the binding of an mRNA aptamer 
tag to the quencher segment of the molecules. The method 
allows real-time detection of mRNA transcripts in vitro.
